Effect of the Stellamune (TM) Mycoplasma vaccin on growth, energy conversion, death, and medication use in fattening pigs on a pig farm chronically infected with Mycoplasma hyopneumoniae
Ft. Bouwkamp et al., Effect of the Stellamune (TM) Mycoplasma vaccin on growth, energy conversion, death, and medication use in fattening pigs on a pig farm chronically infected with Mycoplasma hyopneumoniae, TIJD DIERG, 125(14), 2000, pp. 444-448
The effect of Stellamune(TM) Mycoplasma vaccine, administered to piglets ag
ed 2-15 days and then 13-15 days later, on daily weight gain, energy conver
sion, and use of medication was examined in fattening pigs on a chronically
Mycoplasma hyopneumoniae infected pig farm. Half of the piglets were vacci
nated and the other half acted as controls. In the study design, half of th
e pens in the fattening unit were allocated to vaccinated pigs; the other h
alf to non-vaccinated pigs, pen was the experimental unit. In the fattening
pens sows and castrated boars were separated. The study consisted of a tot
al of 37 pens wit vaccinated, and 37 pens wit non-vaccinated pigs in 12 dif
ferent compartments within the pig herd. In the finishing period, mean grow
th performance and mean energy conversion (EV/kg) of vaccinated animals was
65 grams/day higher and 0.07 EV/kg lower than in control pigs. Furthermore
, the incidence of individual curative medication against respiratory probl
ems was more than 4 times higher in control pigs than in vaccinated pigs. T
here was a tendency for a higher number of group medications against respir
atory problems in control pigs than in vaccinated pigs It is concluded that
, in this herd, vaccination against M. hyopneumoniae was successful from an
economic point of view.